Venture&Growth
Location
Murray Hill (NJ), USA
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
FlowCardia is a medical device company marketing catheters that reopen obstructed arteries in the legs, which can avoid amputation. Its lead product, the CROSSER™, uses high-frequency vibration to penetrate hard arterial blockages.
After Gilde led a large institutional financing round of growth capital, the company built a marketing and sales organization, expanded its product portfolio and developed into a high-growth, revenue-generating business. FlowCardia was acquired by C. R. Bard, Inc. (NYSE: BCR) in 2010. It was located in Sunnyvale, California.
More Flowcardia news
FlowCardia, Inc. Initiates CENTRAL Study Enrollment
FlowCardia, Inc. expands treatment options for patients with chronic total occlusion
FlowCardia, Inc. Launches FlowMate™ Injector to Optimize Performance
FlowCardia, Inc. Appoints Deborah DeFilippo CFO
Venture&Growth
Noema Pharma
Swiss Therapeutics company developing therapies to treat severe neurological disorders.
Venture&Growth
Eargo
US-based MedTech company selling hearing aid solutions to patients suffering from hearing loss.
Venture&Growth
GT Medical Technologies
GT Medical Technologies (GT) is a commercial stage, US-based medical device company that specializes in developing innovative products for the treatment of brain tumors. GT has created a product called GammaTile Therapy, which is an implantable radiation therapy for the
